NEXT GENERATION OF DIABETES CARE IS HERE

FreeStyle Libre 2 iCGM meets highest levels of accuracy standards, with optional alarms and for kids 4 and up.

diabetes management

Jun 15 2020

If you're living with diabetes and you want excellent accuracy, and the longest-lasting integrated continuous glucose monitoring system on the market that gives you glucose readings every minute, there’s only one choice: FreeStyle Libre 2 and its unsurpassed 14-day accuracy1, now available in most U.S. pharmacies.2

How can we say that? Here's how:

  • Only iCGM that measures glucose every minute, meeting the highest level of accuracy standards.3 Every minute counts when it comes to managing diabetes. The FreeStyle Libre 2 system measures every minute, five times more often than other CGMs.4,5
  • Longest lasting self-applied sensor. At 14 days, FreeStyle Libre 2 is the longest-lasting iCGM available, nearly 40 percent longer than the other iCGM.6 And with its built-in shutoff at 14 days, you can trust in its reliability. Simply, it’s unsurpassed 14-day accuracy1.
  • Now for kids 4 and up. That’s right. With U.S. Food and Drug Administration clearance, FreeStyle Libre 2 can be prescribed for children 4 and older with diabetes once available, broadening the impact of this revolutionary technology.
  • A third of the cost. More features, excellent accuracy, significantly lower cost.7 Compared to other CGMs, the FreeStyle Libre 2 system will cost 70% less.
  • Customizable, optional real-time alarms. You’ll know within a minute when your glucose has veered too far from where it should be. Alarms automatically alert you if you’re too high or too low without having to scan.
  • Fewer false alarms for kids 4 and up. The next generation of the FreeStyle Libre technology reduces false alarms for kids by a third compared with the other iCGM available8 in the U.S.

The FreeStyle Libre 2 system, which will be available in the coming weeks, is another step toward resolving the inconveniences that can make it difficult for people to stick to a diabetes management plan. Users have the option of turning off alarms.

For the 34 million Americans living with diabetes, this FDA clearance of the latest version of FreeStyle Libre portfolio is another life-changing experience.

Our revolutionary system builds on its long standard of eliminating the hurdles of traditional glucose monitoring and requiring no routine fingersticks9 — all at significantly lower costs than other CGMs.7

It’s exactly what you expect from a world leading health technology that’s helping people live their best lives.

Around the globe, more than 2 million people are using the FreeStyle Libre system in 50 countries.10 It has been clinically proven to be accurate, stable and consistent.

How does continuous glucose monitoring with the FreeStyle Libre 2 System work?

The FreeStyle Libre 2 system measures glucose levels through a small sensor — the size of two stacked quarters — applied to the back of your upper arm. It provides glucose readings every minute with unsurpassed 14-day accuracy, day and night11, the longest-lasting self-applied iCGM currently available. The sensor can also read glucose levels through clothes,12 making testing discreet and convenient.

The FreeStyle Libre 2 system provides three critical pieces of data with each scan:

  • Current glucose level.
  • An eight-hour historical trend.
  • A directional trend arrow showing where glucose levels are headed.

The touch-screen reader also holds up to 90 days of data, which allows people to track their glucose levels over time.

How does the FreeStyle Libre 2 System help improve treatment?

The data generated by the FreeStyle Libre 2 system is designed to provide actionable trends and patterns that help you make better decisions about your health, such as adjustments to your diet or how much insulin you need to take. For example, the reader's snapshots can reveal if a person is experiencing hypoglycemic trends (low glucose levels) patterns or hyperglycemic trends (high glucose levels), which can aid in choosing the right diabetes management.

Studies show that FreeStyle Libre technology users who scan more frequently spend less time in hypoglycemia and experience improved average glucose levels.13,14 According to a study presented at the Advanced Technologies & Treatments for Diabetes (ATTD) meeting earlier this year in Madrid, people with type 2 diabetes on insulin using the FreeStyle Libre technology saw average HbA1c levels drop significantly.15

Go play, kids. Rest easier, parents. Diabetes doesn't have to control you. FreeStyle Libre 2 will sound the alarm16 if there’s anything to worry about. It's time to live.

1FreeStyle Libre 2 User Guide.

2Participating pharmacies are subject to change without notice. Product availability may vary by retailer.

3Based on FDA iCGM special controls.

4Data on file. Abbott Diabetes Care.

5Dexcom G6 CGM User Guide.

6Based on a comparison to Dexcom G6.

7Based on a comparison of list prices of the FreeStyle Libre 14 day system versus competitors' CGM systems. FreeStyle Libre 2 system will be list priced the same rate as FreeStyle Libre 14 day system. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.

8FreeStyle Libre 2 system user manual. Dexcom G6 CGM User Guide. Based on low glucose alarms set at 70 mg/dl. for pediatrics.

9Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.

10Data on file, Abbott Diabetes Care.

11Based on the sensor being replaced once every 14 days, and scanned at least once every 8 hours.

12The reader can scan through clothing with a thickness of 1-4 cm.

13Canadian real-world analysis of flash glucose monitoring and glycemic control. Presented at the 12th Advanced Technologies & Treatments for Diabetes (ATTD) in Berlin, Germany, Lori Berard, Laura Brandner

14Acute diabetes complications defined by hypoglycemia, hypoglycemic coma, hyperglycemia, ketoacidosis, or hyperosmolarity ICD-10 codes as primary diagnosis for inpatient or as any position in the outpatient emergency claim. Presented at the 12th Advanced Technologies & Treatments for Diabetes (ATTD) in Berlin, Germany. Matthew Kerr, Gregory Roberts, Diana Souto, Yelena Nabutovsky

15Improving HbA1c control in people with Type 1 or Type 2 diabetes using flash glucose monitoring: a retrospective observational analysis in two German centers; Gerhard Klausmann, Ludger Rose. Presented at the 12th Advanced Technologies & Treatments for Diabetes (ATTD) in Berlin, Germany. Alexander Seibold

16Notifications will only be received when alarms are turned on and the sensor is within 20 feet of the reading device.

 

Indications and Important Safety Information

The FreeStyle Libre 2 Flash Glucose Monitoring System is a continuous glucose monitoring (CGM) device with real time alarms capability indicated for the management of diabetes in persons age 4 and older.*

WARNINGS/LIMITATIONS*:
The System must not be used with automated insulin dosing (AID) systems, including closed loop and insulin suspend systems. Remove the sensor before MRI, CT scan, X-ray, or diathermy treatment. Do not take high doses of vitamin C (more than 500 mg per day), as this may falsely raise your Sensor readings. Failure to use the System according to the instructions for use may result in missing a severe low blood glucose or high blood glucose event and/or making a treatment decision that may result in injury. If glucose alarms and readings from the System do not match symptoms or expectations, use a fingerstick blood glucose value to make diabetes treatment decisions. Seek medical attention when appropriate and contact Abbott Toll Free (855-632-8658) or visit * www.freestylelibre.us for detailed indications for use and safety information.

*Please refer to www.freestylelibre.us for the indications and important safety information.

true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?